AB
HUMA icon

Amalgamated Bank’s Humacyte HUMA Stock Holding History

Amalgamated Bank’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,875
Closed -$5K – 2174
2025
Q4 		$5K Buy
4,875
+1,841
+61% +$2.61K ﹤0.01% 2711
2025
Q3 		$5K Hold
3,034
– – ﹤0.01% 2764
2025
Q2 		$6K Hold
3,034
– – ﹤0.01% 2656
2025
Q1 		$5K Buy
3,034
+865
+40% +$3.25K ﹤0.01% 2658
2024
Q4 		$11K Hold
2,169
– – ﹤0.01% 2382
2024
Q3 		$12K Hold
2,169
– – ﹤0.01% 2359
2024
Q2 		$10K Buy
2,169
+309
+17% +$1.61K ﹤0.01% 2443
2024
Q1 		$6K Sell
1,860
-6,183
-77% -$20.8K ﹤0.01% 2642
2023
Q4 		$23K Sell
8,043
-554
-6% -$1.42K ﹤0.01% 2583
2023
Q3 		$25K Hold
8,597
– – ﹤0.01% 2542
2023
Q2 		$25K Buy
8,597
+630
+8% +$2.27K ﹤0.01% 2626
2023
Q1 		$25K Sell
7,967
-2,498
-24% -$7.1K ﹤0.01% 2565
2022
Q4 		$22K Buy
10,465
+6,013
+135% +$18.3K ﹤0.01% 2725
2022
Q3 		$15K Buy
4,452
+43
+1% +$165 ﹤0.01% 2878
2022
Q2 		$14K Buy
+4,409
New +$24.5K ﹤0.01% 2930

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Amalgamated Bank's HUMA Position: Q1 2026 in Review

Amalgamated Bank sold out of Humacyte (HUMA) in Q1 2026, closing a stake of 4,875 shares — an estimated $5K sold.

Amalgamated Bank first reported a position in HUMA in Q2 2022 and held it in 15 quarters. The position peaked at $25K in Q3 2023. 159 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Amalgamated Bank reported no remaining Humacyte position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,875 Humacyte shares in Q1 2026, an estimated $5K.
  • Amalgamated Bank first reported a position in Humacyte in Q2 2022 and held it in 15 quarters.
  • Amalgamated Bank's Humacyte position peaked at $25K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.